Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Asia Pramulia Tbk. (ASPR) vs UBC Medical Indonesia Tbk. (LABS)

Asia Pramulia Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Asia Pramulia Tbk. dan UBC Medical Indonesia Tbk.: Asia Pramulia Tbk. diperdagangkan di Rp153 (kapitalisasi pasar 409,51 M, volume 24 jam 6,14 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp163 (kapitalisasi pasar 635,95 M, volume 24 jam 168,8 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Asia Pramulia Tbk. lebih aktif diperdagangkan (6,14 jt vs 168,8 rb). Mana yang lebih baik tergantung tujuan investasimu.

ASPRLABS
Kapitalisasi Pasar
409,51 M635,95 M
Volume
6,14 jt168,8 rb
Lot
61,41 rb1,69 rb
Perputaran
933,57 jt27,48 jt
Harga Rata-rata
152,03162,82
Nilai Transaksi
933,57 jt27,48 jt
Harga Ekuilibrium Indikatif
153163
Volume Ekuilibrium Indikatif
2,49 rb16

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ASPR
Lihat detail
LABS
Lihat detail

Tentang Asia Pramulia Tbk.

PT Asia Pramulia Tbk (Entity) was established based on deed No. 193 dated July 29, 1991 from Noor Irawati, S.H., Notary in Surabaya.

Selengkapnya di halaman ASPR

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS